Post by Amgen

Name: What does progress in biosimilars look like? At Amgen, it started with our first biosimilar approv
Uploaded: 2026-06-10T14:06:36.378Z
Channel: Amgen
Description: What does progress in biosimilars look like? At Amgen, it started with our first biosimilar approval in 2016. Today, our portfolio includes eight FDA-approved biosimilars — with more in the pipeline

1,761,721 followers

What does progress in biosimilars look like? At Amgen, it started with our first biosimilar approval in 2016. Today, our portfolio includes eight FDA-approved biosimilars — with more in the pipeline. In Inside Biosimilars, Marc Doble, Vice President and General Manager, Biosimilars, and Jessica Akopyan Assoc. Vice President, Corporate Affairs, Global Markets, discuss the momentum behind Amgen’s biosimilars portfolio, the expertise behind it and the opportunities ahead. Watch their conversation to learn more. #Biosimilars

Video Content